Answers are grounded in this paper and cite their sources.
BACKGROUD: Intraperitoneal injections of contrast agents have been associated with peritoneal inflammation in animals. This study investigated the effects of intraperitoneal injection of iohexol during computed tom ography (CT) peritoneogruphy on peritoneal transport characteristics and ultrafiltration capacity in continuous ambulatory peritoneal dialysis (CAPD) patients. METHODS: Eighteen patients (7 men, 11 women; average age, 59.9 ± 3.3 years; range, 31.9-86.5 years; average time on peritoneal dialysis, 2.6 ± 0.4 years; range, 0.01-6.1 years) underwent CT perito-neography. Data on peritoneal transport type and ultrafiltration capacity were obtained before CT perltoneography and during follow-up. The paired r-test was used to compare the dialysate to plasma (DIP) ratio of creatinine and ultrafiltration capacity before and after peritoneography. RESULTS: The average length of time from pre-CT peritoneal equilibrium test to CT peritoneography was 3.5 ± 0.4 months (range, 0.8-6.0 months) and from CT peritoneography to post-CT peritoneal equilibrium test was 2.5 ± 0.4 months (range, 0.6-6.1 months) . No significant differences were found between baseline DIP creatinine ratios, ultrafiltration capacity, residual renal function (RRF), renal clearance of creatinine (CCr) and peritoneal CCr, and those recorded within 6 months after CT peritoneography. Conclusion: CT peritoneography using iohexol had no adverse effect on peritoneal transport or ultrafiltration capacity within 6 months after CAPD.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: